Treace Medical Concepts (TMCI) Current Assets (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Current Assets came in at $120.5 million in Q2 2026, down 18.39% on a YoY basis from $147.6 million in Q2 2025, and down 2.44% quarter-over-quarter from $123.5 million in Q1 2026.
Analysis
Treace Medical Concepts (TMCI) Current Assets (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has reported Current Assets for 7 consecutive years, with $120.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Assets fell 18.39% year-over-year to $120.5 million; the trailing twelve-month figure through Jun 2026 stood at $120.5 million (down 18.39% YoY), and the FY2025 full-year result was $132.1 million, down 18.18% from the prior year.
- Current Assets slipped to $120.5 million in Q2 2026 per TMCI's latest filing, from $123.5 million in the prior quarter.
- Across five years, Current Assets topped out at $223.1 million in Q1 2023 and bottomed at $120.5 million in Q2 2026.
- Historically, Current Assets has averaged $156.6 million across 5 years, with a median of $148.5 million in 2025.
- The sharpest annual moves came in 2022 and 2025: Current Assets soared 249.25% in 2022, then slipped 20.26% in 2025.
- Over 5 years, Current Assets stood at $133.4 million in 2022, then surged by 48.69% to $198.4 million in 2023, then fell by 18.63% to $161.4 million in 2024, then slipped by 18.18% to $132.1 million in 2025, then retreated by 8.78% to $120.5 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $120.5 million, $123.5 million, and $132.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 9.54 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 24.39 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 14.42 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 7.97 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 6.82 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 6.62 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 4.09 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 2.45 Bn |
| 10 | Treace Medical Concepts | 294.68 Mn | 249.06 Mn | 35.61 Mn | 120.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 120.45 Mn |
| Mar 31, 2026 | 123.47 Mn |
| Dec 31, 2025 | 132.05 Mn |
| Sep 30, 2025 | 138.00 Mn |
| Jun 30, 2025 | 147.60 Mn |
| Mar 31, 2025 | 149.44 Mn |
| Dec 31, 2024 | 161.40 Mn |
| Sep 30, 2024 | 157.60 Mn |
| Jun 30, 2024 | 171.55 Mn |
| Mar 31, 2024 | 187.40 Mn |
| Dec 31, 2023 | 198.36 Mn |
| Sep 30, 2023 | 187.14 Mn |
| Jun 30, 2023 | 198.10 Mn |
| Mar 31, 2023 | 223.13 Mn |
| Dec 31, 2022 | 133.40 Mn |
| Sep 30, 2022 | 127.90 Mn |
| Jun 30, 2022 | 135.20 Mn |
| Mar 31, 2022 | 127.31 Mn |
| Dec 31, 2021 | 137.97 Mn |
| Sep 30, 2021 | 135.37 Mn |